Shengbang shares: it is proposed to participate in the investment and establishment of a partnership with RMB 40million
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Real Estate, Consumer Discretionary, IndustrialsTech for Global, Globalization Footprints of the Established and the New
Junpu Intelligence: the winning rate is 0.03616551%
AI-driven Biotech Galixir Nominates Preclinical Candidate in Treating Autoimmune Disease
Founded in 2019, Galixir named a Preclinical Candidate (PCC) for the treatment of Autoimmune Disease (AID) which was screened out of around 80 compounds via its proprietary platform, Pyxir®, making it another top-ranking China-based AI-driven drug discovery company.
Jun 21, 2022 01:44 PM
France launches national quantum computing platform
Semiconductor chip stocks rose in early trading
Shengbang shares: it is proposed to subscribe for the share of Suzhou Yaotu equity investment with RMB 30 million
Where Will AI Take Drug Discovery in China to?
The development of drug discovery in China is relatively slower than in many other countries but China’s pharma market size is among the top three worldwide. Deeper exploration of drug discovery is much needed in China. AI can make a machine execute tasks like a human or even better than humans. With many emerging AI-powered drug discovery companies in China, can AI help China beat the pioneers in drug discovery at their own game?
Jun 21, 2022 01:19 PM
ArtechMed Completes Nearly 100 Million CNY in Series C Round
ArtechMed has completed its Series C funding round, which totaled nearly 100 million CNY. 张科禾润基金 led this round of funding, which is followed by 黄埔医药基金 and Sunland Fund. Follow-up investments were also made by Dingxin Capital.
Jun 17, 2022 07:16 PM
Kailitai: it plans to apply to the government of Pudong New Area of Shanghai for the recognition of the headquarters of large enterprises
Robin Li: Baidu has become the world's largest automated driving service provider.
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM